CFO of 17 Education (NASDAQ: YQ) reports large multi-year option grants

Rhea-AI Filing Summary

17 Education & Technology Group Inc. disclosed that its Chief Financial Officer, Zhou Sishi, holds several option awards over the company’s Class A ordinary shares at an exercise price of $0.0014 per share. Earlier grants from January 10, 2021 and July 10, 2021 are fully vested, with 23,360 and 25,000 options respectively remaining exercisable after prior exercises.

Additional options were granted on October 10, 2024 for 900,000 shares, vesting in three equal annual installments starting that date. On October 10, 2025, Zhou received options over 3,000,000 shares that vest in three equal annual installments from the grant date, plus a further 2,000,000 options that vest in two tranches if specified performance targets are achieved within a three-year period. No open‑market purchases or sales are reported; this filing outlines existing option holdings and their vesting terms.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zhou Sishi

(Last) (First) (Middle)

16/F, BLOCK B,

WANGJING GREENLAND CENTER, CHAOYANG

(Street)

BEIJING F4 100102

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026

3. Issuer Name and Ticker or Trading Symbol
17 Education & Technology Group Inc. [ YQ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	(1)	01/10/2031	Class A ordinary shares	23,360(1)	$0.0014	D
Options	(2)	07/10/2031	Class A ordinary shares	25,000(2)	$0.0014	D
Options	(3)	10/10/2034	Class A ordinary shares	900,000(3)	$0.0014	D
Options	(4)	10/10/2035	Class A ordinary shares	3,000,000(4)	$0.0014	D
Options	(5)	10/10/2035	Class A ordinary shares	2,000,000(5)	$0.0014	D

Explanation of Responses:

1. On January 10, 2021, the reporting person was granted the options to purchase 50,000 Class A ordinary shares of 17 Education & Technology Group Inc. (the "Company"). These options have been fully vested, of which 26,640 options have been exercised and 23,360 options remain exercisable.

2. On July 10, 2021, the reporting person was granted the options to purchase 50,000 Class A ordinary shares of the Company. These options have been fully vested, of which 25,000 options have been exercised and 25,000 options remain exercisable.

3. On October 10, 2024, the reporting person was granted the options to purchase 900,000 Class A ordinary shares of the Company. These options vest in three equal annual installments beginning on the grant date, i.e., October 10, 2024.

4. On October 10, 2025, the reporting person was granted the options to purchase 3,000,000 Class A ordinary shares of the Company. These options vest in three equal annual installments beginning on the grant date, i.e., October 10, 2025.

5. On October 10, 2025, the reporting person was granted the options to purchase 2,000,000 Class A ordinary shares of the Company. These options are subject to performance-based vesting conditions and will vest in two tranches upon the achievement of certain performance targets within a three-year period.

	/s/ Sishi Zhou	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider holdings does YQ CFO Zhou Sishi report in this Form 3?

Zhou Sishi reports multiple option grants over Class A ordinary shares at an exercise price of $0.0014 per share. These include fully vested 2021 grants and larger awards from 2024 and 2025 with time-based and performance-based vesting schedules.

How many of Zhou Sishi’s earlier YQ option grants remain exercisable?

The 2021 option grants leave 23,360 and 25,000 options exercisable after prior exercises. Footnotes state the January and July 2021 awards are fully vested, with part already exercised and the remaining options still available to be exercised by the CFO.

What are the vesting terms for Zhou Sishi’s 2024 YQ option grant?

The October 10, 2024 grant covers options to purchase 900,000 Class A ordinary shares. According to the disclosure, these options vest in three equal annual installments beginning on the grant date, spreading vesting over a three-year period tied to continued service.

What performance-based options does the YQ CFO hold from 2025 grants?

On October 10, 2025, Zhou received options for 2,000,000 shares subject to performance-based vesting. These options vest in two tranches once certain performance targets are met within a three-year period, aligning part of compensation with achieving company performance goals.

Are there any reported share purchases or sales by YQ’s CFO in this filing?

The disclosure lists option holdings and vesting details but does not report open‑market purchases or sales. It describes grants, vesting schedules, and remaining exercisable options, rather than new market transactions in the company’s Class A ordinary shares.

What are the expiration dates for the YQ options held by the CFO?

The options expire between January 10, 2031 and October 10, 2035, depending on grant. Each option series has a specific expiration date, giving Zhou a long-term window to exercise vested options, subject to their respective vesting and performance conditions.